Beruflich Dokumente
Kultur Dokumente
n e w e ng l a n d j o u r na l
of
m e dic i n e
1487
The
n e w e ng l a n d j o u r na l
of
m e dic i n e
Day of Admission,
Other Hospital
On Admission,
This Hospital
Hematocrit (%)
41.053.0 (men)
56.1
49.2
Hemoglobin (g/dl)
13.517.5 (men)
18.9
16.9
450011,000
17,500
20,600
Neutrophils
4070
66.4
63
Lymphocytes
2244
14.3
24
411
18.5
Variable
Monocytes
Eosinophils
08
0.6
Basophils
03
0.2
Band forms
010
150,000400,000
194,000
120,000
22.134.0
34.3
>150.0
10.313.2
16.7
29.6
<500
>1000
1.59
(ng/ml)
Fibrinogen (mg/dl)
150400
Sodium (mmol/liter)
135145
Potassium (mmol/liter)
3.44.8
116
141
5.9
Chloride (mmol/liter)
100108
105
23.031.9
825
32
0.601.50
>60
70110
3.1
>10,000
132
8.0 (not hemolyzed)
104
13.7
31
3.0
2.86
27
29
144
164
Bilirubin (mg/dl)
Total
0.01.0
0.9
0.7
Direct
0.00.4
0.3
Total
6.08.3
3.4
Albumin
3.35.0
1.9
Protein (g/dl)
Phosphorus (mg/dl)
2.64.5
Magnesium (mg/dl)
1.72.4
Calcium (mg/dl)
8.510.5
1.141.30
45115
3.2
6.2
1.11
48
1.00
120
1040
25
1081
1055
30
1238
Lipase (U/dl)
1.36.0
Amylase (U/liter)
Creatine kinase (U/liter)
1488
9.9
3.8 (ref 1.73.0)
3100
60400 (men)
2.5
3.9
23
52
1100
Table 1. (Continued.)
Reference Range, Adults,
This Hospital
Variable
Day of Admission,
Other Hospital
On Admission,
This Hospital
Troponin
Ultra troponin (ng/ml)
Troponin I
Negative
Troponin T (ng/ml)
0.000.09
Ammonia (mol/liter)
1248
Lactate (mmol/liter)
0.52.2
Ethanol (mg/dl)
Negative
<0.01
250
553
15.7
1 (ref 010)
* Ref denotes reference range. To convert the values for glucose to millimoles per liter, multiply by 0.05551. To convert
the values for urea nitrogen to millimoles per liter, multiply by 0.357. To convert the values for creatinine to micromoles per liter, multiply by 88.4. To convert the values for bilirubin to micromoles per liter, multiply by 17.1. To convert
the values for phosphorus to millimoles per liter, multiply by 0.3229. To convert the values for magnesium to millimoles per liter, multiply by 0.4114. To convert the values for calcium to millimoles per liter, multiply by 0.250. To convert the values for ionized calcium to milligrams per deciliter, divide by 0.250.
Reference values are affected by many variables, including the patient population and the laboratory methods used. The
ranges used at Massachusetts General Hospital are for adults who are not pregnant and do not have medical conditions that could affect the results. They may therefore not be appropriate for all patients.
DIFFER EN T I A L DI AGNOSIS
Dr. Hasan B. Alam: May we review the radiologic
studies?
Dr. Alexander S.R. Guimaraes: Contrast-enhanced
CT images of the abdomen and pelvis from the
other hospital (Fig. 1) show diffuse distention of
the entire colon. There is fecal material through-
1489
The
n e w e ng l a n d j o u r na l
of
m e dic i n e
Variable
Day of Admission,
Other Hospital
On Admission,
This Hospital
1.00
1.00
<6.80
6.93
7.327.45
3550
88
66
4090
52.7
63
52.8
24.5
20.2
7.327.45
6.88
7.01
3542
77
63
80100
381
281
99.5
Alveolararterial gradient
249
20.5
16.7
* Reference values are affected by many variables, including the patient population and the laboratory methods used. The
ranges used at Massachusetts General Hospital are for adults who are not pregnant and do not have medical conditions that could affect the results. They may therefore not be appropriate for all patients.
dition known as acute megacolon (Ogilvies syndrome). He also has thickening of the wall of the
colon, which suggests inflammation, and septic
shock with multiple organ failure; the combination of colonic distention (>6 cm in diameter)
associated with inflammation of the colon and
septic shock is known as toxic megacolon.1,2 In
a young patient, the most common cause of
toxic megacolon is inflammatory bowel disease,
which this patient did not have. The other leading cause often not associated with diarrhea
is colitis due to Clostridium difficile. However,
C. difficile colitis usually occurs in patients who
are taking multiple antibiotics again, not the
case in this patient.
In addition to colonic distention, shock, and
organ failure, this patient had a distended and
rigid abdomen and increased peak airway pressures. These findings are consistent with an
abdominal compartment syndrome, defined as
a sustained intraabdominal pressure above 20
mm Hg (with or without an abdominal perfusion
pressure below 60 mm Hg) that is associated with
organ dysfunction or failure.3,4 This condition is
being recognized with increasing frequency in
critically ill patients, including those with septic
shock,5 and has been identified as an independent predictor of death in such patients.6
1491
The
n e w e ng l a n d j o u r na l
of
m e dic i n e
Fluid
Ascites
Infected ascites
Acute liver failure
Gas
Blood
Aortic-aneurysm leak
Solid-organ bleeding
(spleen or liver)
Mesenteric bleeding
Extraluminal cause
(bowel perforation)
Intraluminal causes
Obstructive
Volvulus
Tumors
Stricture
Nonobstructive
Motility disorders
Inflammation
Infection
Ischemia
EMail
Enon
ARTIST: ts
Line
H/T
Combo
4-C
H/T
Revised
SIZE
33p9
Dr. Lawrence R. Zukerberg: The removed segment of Acute megacolon that occurs in association with
colon was dilated, ranging from 15 to 18 cm in underlying inflammation, such as inflammatory
diameter, and filled with bloody fecal material. bowel disease or C. difficile disease, is known as
1492
Dr. Gregory L. Fricchione: This mans psychiatric illness is marked by an early onset (at the age of 16
years), inpatient commitment in the state-hospital
system for 3 years, and trials of many antipsy-
1493
The
n e w e ng l a n d j o u r na l
of
m e dic i n e
diaphoresis may lower the threshold for constipation and its more serious outcomes.23
This patients clozapine dose was 550 mg per
day higher than the mean dose in the reported
cases of clozapine-induced gastrointestinal hypo
motility (428 mg per day) and higher than the
dose for those who died (535 mg per day). Our
patient was also receiving an anticholinergic
medication (glycopyrrolate), presumably for clozapine-induced hypersalivation, and was also taking valproate, which can cause a minor increase
in clozapine metabolites.29 We do not know exactly how long the patient had been taking clozapine, but it was at least several months and
possibly more than a year. In the reported cases,
20% of cases of clozapine-induced gastrointestinal hypomotility developed within 1 month after
the start of treatment with clozapine, 36% with
in 4 months, and more than 50% within the
first year.
Serious complications usually develop in patients with clozapine-induced gastrointestinal hypomotility between 6 hours and 4 weeks after
initial reports of problems. This patient had abdominal distention for several weeks and then
acute symptoms on the evening before admission.
Patients with schizophrenia may have a higher
pain threshold than other patients, as well as difficulty in expressing pain.30 Psychotropic medications themselves may cause sedation and antinociception. A combination of these factors
may delay the diagnosis, as they probably did in
this case.
Before clozapine is administered, preexisting
constipation should be treated, and education
about diet, food intake, dehydration, and exercise should be provided. Regular weekly screening during the first 4 months of clozapine treatment is advised, with attention to constipation,
a change in bowel habits, and abdominal girth.23
This case, in which gastrointestinal complications developed at least several months after the
start of treatment with clozapine, suggests that
the screening period should probably be extend
ed. Avoidance of concomitant medications that
can cause constipation, such as opiates and anti
cholinergic medications, is recommended. The
gradual development of abdominal distention in
this patient, in the context of the administration
of clozapine and glycopyrrolate, should have
prompted consideration of discontinuation of
these medications. This case highlights the morbidity and mortality associated with clozapine-
induced gastrointestinal hypomotility and the reason, a motion for temporary guardianship,
importance of screening.
accompanied by a medical certificate, and a
Rogers guardianship were filed 12 weeks into
this hospitalization and received court approval
Discussion of M a nagemen t
at approximately week 15. A Rogers guardianDr. Harris: I would like to ask Drs. Ustin and Fer- ship supplements regular guardianship when it
nandez-Robles, who cared for this patient on the is deemed necessary for safety reasons to give
Surgical and Psychiatry services, respectively, to psychiatric medications against a patients will.
tell us how the patients care was managed and The patients father is the current Rogers guardhow he is doing.
ian and legal guardian. Six months after the
Dr. Ustin: The patient required many additional patients admission, the temporary guardianship
operations, including resection of ischemic ileum, that we filed for was extended by 90 days, because
creation of an ileostomy, delayed abdominal clo- he was still on our psychiatric unit.
sure, drainage of an intraabdominal hematoma,
This has been a very challenging case for us.
and placement of a tracheostomy tube. He had Clozapine is reserved for cases in which several
profound multisystem organ failure with septic trials of antipsychotic agents have been unsucshock, a peak lactate level of 24 mmol per liter, cessful, and it was the one medication that
liver failure with a total bilirubin level of 44 mg seemed to control this patients psychosis. Severe
per deciliter (752 mol per liter), renal failure clozapine-induced gastrointestinal hypomotility
requiring 2 months of renal-replacement thera- developed, but after his colon was removed, we
py, and respiratory failure requiring 2 months of thought it would be safe to offer him this drug
mechanical ventilation. Approximately 1 week again. Unfortunately, he refuses to take it beinto his hospitalization, he had received 55 units cause it had caused acute megacolon. Although
of packed red cells, 70 units of platelets, and 134 his father could order it under the terms of the
units of fresh-frozen plasma for severe coagu Rogers guardianship, he has declined to do so.
lopathy and bleeding. Because of gastrointesti- We first started a trial of olanzapine (10 to 20 mg
nal dysfunction and the short-gut syndrome, he daily for 17 weeks), with insufficient response.
required parenteral nutrition. Pulmonary mucor We then switched to risperidone, and the dose was
mycosis and heparin-induced thrombocytopenia increased to 8 mg per day, which is the higher
developed and required placement of an inferior end of the therapeutic dosage range. Most revena cava filter during the postoperative period. cently, aripiprazole (5 mg) was added. Within the
Ultimately, after 4 months on the surgical past month, he also received a trial of ziprasiservice, the patients renal and kidney function done because of a persistently irritable mood, but
returned to normal and he was weaned from the it was discontinued because it was ineffective.
ventilator and transitioned to tube feeding and
During the patients stay in the psychiatric
then to an oral diet. He was ambulatory and unit, additional medical problems were addressed:
gaining weight and was transferred to the psychi tachycardia, anemia, renal failure, hypercalcemia,
atry service for management of schizophrenia.
and physical deconditioning. His medical condiDr. Carlos Fernandez-Robles (Psychiatry): When I tion stabilized, and he became independent in
saw this patient for the first time, he was still in activities of daily living. He continued to display
the ICU, intubated and sedated and not requir- guarded, paranoid behavior and did not acknowling antipsychotic medications. Once his medical edge that he had any psychiatric condition. An
condition stabilized, treatment with olanzapine oral, dissolving preparation of risperidone (Risper(10 mg per day) was begun; while he was in the dal M-Tabs) was required, to prevent him from
ICU, he received all required doses of this medi- spitting out the medication. He was transferred to
cation, and his psychosis was well controlled. a state hospital after a total of 6 months in this
After his transfer to the regular surgical ward, hospital. Three months later, he was discharged
he began refusing psychiatric medications, and to a halfway house. His psychiatric symptoms
his psychiatric problems recurred.
are reasonably well controlled with risperidone
His behavior was oppositional, and he refused and oxcarbazepine. The colostomy was reversed
essential medications and procedures, including 6 months after discharge, 13 months after his
the administration of intravenous fluids. For this initial admission to this hospital.
n engl j med 361;15 nejm.org october 8, 2009
1495
references
1. Berman L, Carling T, Fitzgerald TN,
analysis from the German Trauma Registry on 8724 patients. Injury 2007;38:298304.
11. Niles SE, McLaughlin DF, Perkins JG,
et al. Increased mortality associated with
the early coagulopathy of trauma in combat casualties. J Trauma 2008;64:1459-63.
12. Rotondo MF, Schwab CW, McGonigal
MD, et al. Damage control: an approach
for improved survival in exsanguinating
penetrating abdominal injury. J Trauma
1993;35:375-83.
13. Lee JC, Peitzman AB. Damage-control
laparotomy. Curr Opin Crit Care 2006;12:
346-50.
14. Maerz L, Kaplan LJ. Abdominal compartment syndrome. Crit Care Med 2008;
36:Suppl:S212-S215.
15. Rivers E, Nguyen B, Havstad S, et al.
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
N Engl J Med 2001;345:1368-77.
16. Sebat F, Johnson D, Musthafa AA, et al.
A multidisciplinary community hospital
program for early and rapid resuscitation
of shock in nontrauma patients. Chest
2005;127:1729-43.
17. Shapiro NI, Howell MD, Talmor D, et
al. Implementation and outcomes of the
Multiple Urgent Sepsis Therapies (MUST)
protocol. Crit Care Med 2006;34:1025-32.
18. Dellinger RP, Levy MM, Carlet JM, et
al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit
Care Med 2008;36:296-327.
19. Bharucha AE, Phillips SF. Megacolon:
acute, toxic, and chronic. Curr Treat Options Gastroenterol 1999;2:517-23.
20. Hanauer SB, Wald A. Acute and chronic megacolon. Curr Treat Options Gastroenterol 2007;10:237-47.
21. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996;334:110615.
Lantern Slides Updated: Complete PowerPoint Slide Sets from the Clinicopathological Conferences
Any reader of the Journal who uses the Case Records of the Massachusetts General Hospital as a teaching exercise or reference
material is now eligible to receive a complete set of PowerPoint slides, including digital images, with identifying legends,
shown at the live Clinicopathological Conference (CPC) that is the basis of the Case Record. This slide set contains all of the
images from the CPC, not only those published in the Journal. Radiographic, neurologic, and cardiac studies, gross specimens,
and photomicrographs, as well as unpublished text slides, tables, and diagrams, are included. Every year 40 sets are produced,
averaging 50-60 slides per set. Each set is supplied on a compact disc and is mailed to coincide with the publication of the
Case Record.
The cost of an annual subscription is $600, or individual sets may be purchased for $50 each. Application forms for the current
subscription year, which began in January, may be obtained from the Lantern Slides Service, Department of Pathology,
Massachusetts General Hospital, Boston, MA 02114 (telephone 617-726-2974) or e-mail Pathphotoslides@partners.org.
1496